{
}
Barclays PLC has disclosed its securities positions in Dalata Hotel Group amid an ongoing takeover process, revealing a 1.20% interest and a 1.23% short position in the company's securities, as mandated by Irish Takeover Panel rules. This disclosure highlights Barclays' strategic involvement in the market, potentially impacting stakeholders in the takeover bid.
Japan's GDP per capita is projected to plummet from 29th to 45th globally by 2075, with real GDP expected to grow to $4.4 trillion but drop its global ranking from fourth to 11th. Contributing factors include a declining population, low fertility rates, and limited benefits from AI advancements, necessitating urgent labor reforms to boost productivity. Meanwhile, emerging markets like India are set to rise significantly, with BRICS nations projected to surpass the US in total GDP by 2075.
WhatsApp has received backing from Advocate General Tamara Capeta of the European Court of Justice in its challenge against a €225 million fine imposed by Ireland’s data protection authority in 2021 for privacy violations. Capeta's non-binding opinion, issued on March 27, deems the challenge admissible and suggests it should be reconsidered by the General Court. The fine was influenced by the European Data Protection Board following complaints about WhatsApp's handling of personal data.
Barclays PLC has disclosed its positions in Dalata Hotel Group PLC, revealing a total interest of 1.21% and short positions of 1.23%, in compliance with the Irish Takeover Panel Act. This announcement enhances transparency regarding Barclays' involvement with Dalata, which may influence market perceptions and investor decisions. Barclays is a leading global financial services provider, operating in over 40 countries and serving more than 48 million customers worldwide.
UBS has reiterated a Neutral rating on Royalty Pharma (NASDAQ: RPRX) with a target price of USD 33, despite the stock's 24.5% year-to-date gain. The company faces potential risks from changes in tax legislation, particularly concerning its zero tax rate structure, but is expected to remain profitable with projected earnings growth.In its recent fourth-quarter results, Royalty Pharma reported an EPS of USD 0.3531 and sales of USD 594 million, both below expectations. However, it achieved portfolio revenues of USD 2.8 billion for 2024 and plans a USD 2 billion share buyback, while Citi maintains a Buy rating with a target of USD 40, citing stability in its tax structure.
UBS has added Euronext NV to its "30 for 30" global equity focus list, citing its potential to benefit from increased European trading volumes and volatility. The investment bank highlights Euronext's strong financial performance, with a 15.1% rise in adjusted EBITDA in 3Q24, and its strategic initiatives aimed at achieving over 5% revenue and EBITDA growth through 2027. Bank Mandiri was removed from the list due to ongoing margin pressures in Indonesia.
UBS has added Euronext NV to its "30 for 30" global stock list, replacing Bank Mandiri, citing Euronext's potential to benefit from a recovery in European trading volumes and its strong financial performance, with a 15.1% increase in adjusted EBITDA in Q3 2024. The investment bank highlights Euronext's attractive valuation and growth initiatives, while noting risks related to market volatility and regulation. Other companies on the list include Microsoft, Alibaba, Meta Platforms, and Goldman Sachs, reflecting a focus on technology disruptors in rapidly transforming sectors.
Deutsche Bank has raised its price target for Alkermes plc to $52 from $40 while maintaining a Buy rating. The Ireland-based biopharmaceutical company focuses on developing treatments for neurological disorders, with products like LYBALVI, ARISTADA, and VIVITROL addressing conditions such as schizophrenia and bipolar I disorder. Alkermes also has a pipeline of candidates in various stages of development.
President Donald Trump has announced a 25% tariff on all auto imports not made in the United States, effective April 3. Tesla CEO Elon Musk indicated that this tariff will significantly impact the cost of parts sourced from abroad for Tesla vehicles. Trump also mentioned plans for additional tariffs on pharmaceuticals, emphasizing a fair approach to trade.
Deutsche Bank has raised its price target for Alkermes to $52, up from the previous target of $40. This adjustment reflects a positive outlook on the company's performance in the market.
IRL
Country
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
barclays reveals stake in dalata hotel group during takeover process
16:15 28.03.2025
japan's economic decline projected by 2075 amid population challenges and reforms
United States Dollar
Indian Rupee
South Korean Won
Russian Ruble
Chinese Yuan
Nikkei Asia300 Investable Index
LUX
KAZ
KOR
CHN
IRL
CZE
BRN
IND
RUS
CHE
USA
SVN
BRA
JPN
Donald Trump
Show more
10:32 28.03.2025
whatsapp receives eu court backing in privacy fine appeal
03:45 28.03.2025
barclays reveals positions in dalata hotel group securities compliance update
16:25 27.03.2025
ubs maintains neutral stance on royalty pharma with stable price target
15:14 27.03.2025
Euronext joins UBS global equity focus list amid strong growth prospects
15:06 27.03.2025
ubs adds euronext to global stock list amid positive growth outlook
Euro
Euronext N.V.
Microsoft Corp
The Goldman Sachs Group, Inc.
PT Bank Mandiri (Persero) Tbk
Meta Platforms, Inc.
IDN
FRA
NOR
IRL
PRT
ITA
BEL
Sacha Holderegger
Hartmut Issel
Show more
15:04 27.03.2025
Deutsche Bank raises Alkermes price target and maintains buy rating
13:08 27.03.2025
Trump announces 25 percent tariff on auto imports affecting Tesla parts prices
10:53 27.03.2025
Alkermes price target increased to fifty two dollars by Deutsche Bank
09:50 27.03.2025
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Banking Regulations
Retail and Consumer Goods
Finance Mergers & Acquisitions
Global Financial Events
CEO Changes
Industry Mergers & Acquisitions
Startups & Entrepreneurship
Financial Scams and Security
Market Analysis and Predictions
Supply Chain Management
Global Trade Developments
Central Bank Actions
Government Economic Policies
Workplace Trends
Government Policies
Energy Sector Developments
European Securities and Markets Authority
Countries:
Companies:
JPMorgan Chase & Co.
Tesla, Inc.
Barclays PLC
The Goldman Sachs Group, Inc.
Deutsche Bank Money Market PP
Bank of America Corporation
Morgan Stanley
Wells Fargo & Company
Citigroup Inc.
Credit Suisse Strategic Income I
Commerzbank AG
UBS Group AG
UniCredit S.p.A.
Apple Inc.
Amazon.com, Inc.
NVIDIA Corporation
Lloyds Banking Group plc
BNP Paribas SA
Basler Kantonalbank
Google Inc.
Currencies:
United States Dollar
Euro
Swiss Franc
British Pound Sterling
Chinese Yuan
Indian Rupee
Japanese Yen
United Arab Emirates Dirham
Canadian Dollar
Swedish Krona
Australian Dollar
Mexican Peso
Hong Kong Dollar
Brazilian Real
Danish Krone
Offshore Chinese Yuan
Singapore Dollar
Thai Baht
Indonesian Rupiah
Kuwaiti Dinar
People: